Investors in Ar

RunwayFBU is an early stage VC fund investing in software-driven tech companies, supporting global entrepreneurs with a $30M fund and founder-friendly approach. We believe the use of data and technology is instrumental in creating value.

Easo Ventures is a Basque Private Venture Capital Company created with the aim of supporting people and companies that have a clear growth project, providing investment, advice and experience. They focus on partnering with innovative projects that demonstrate clear growth potential and are in their initial phases of development, led by capable entrepreneurs. Their offerings include an Acceleration Program hosted at BerriUp and an investment amounting to €50,000, with further details accessible at BerriUp.com. Moving into Phase 1, they prioritize companies equipped with a well-defined growth strategy and a proven business model, supported by a capable team capable of managing and expanding the project. In this phase, investments range from €100,000 to €1 million, complemented by comprehensive support and advisory services provided by their experienced team.

Myelin VC is Investing in companies that accelerate collective intelligence. They collaborate with visionary outliers to pioneer the unimaginable, investing in founders whose ideas shape a future they envision living in. Their investment strategy spans across industries, from seed funding to Series A, supporting innovative ventures poised to disrupt and redefine their respective fields.

Vento is an investment firm that seeks Spanish companies with high growth potential and dedicated teams offering exceptional products in sectors such as the complete water cycle, smart cities, distributed electricity production, cybersecurity, Big Data, IoT, and food. Their investment focus is on technology-based firms with proven market-tested products. They prioritize projects led by cohesive and experienced teams committed to their vision. Additionally, they target ambitious ventures capable of market transformation and international leadership. Their investment approach typically involves taking minority stakes through capital increases or participating loans.

7r Ventures operates as a Corporate Venture Builder, specializing in designing, constructing, and investing in cash-flow driven tech startups that address real challenges within traditional industries. Collaborating closely with passionate entrepreneurs, major corporates, and selected investment partners, they employ an iterative model to transform ideas into scalable and profitable ventures. Their approach is distinguished by a focus on a select number of meticulously curated opportunities annually. Drawing from extensive experience in Silicon Valley, where they developed high-tech products for tech giants and managed Corporate Venture Capital portfolios for leading corporations, 7r Ventures brings a unique perspective to innovation and entrepreneurship. Their goal is to launch 2-3 new tech companies each year, with plans already underway to establish 10-15 enterprises over the next five years.

Archipélago Next operates as a Venture Capital fund located in the Canary Islands, Spain, specializing in seed-stage digital startups across Europe. Managed by a team of seasoned professionals and supported by key local industrial players, the fund integrates their expertise into the investment process. With a collaborative investment approach, Archipélago Next actively engages with startups in its portfolio, offering strategic guidance, network access, and financial backing. The fund's mission is to foster the growth of the entrepreneurial ecosystem in the Canary Islands and mainland Spain, facilitating the realization of startups' full potential.

Oceanflow Ventures is a group of business angels and entrepreneurs with global experience in the digital space. Drawing from both their successes and failures, they invest where they can make a meaningful contribution. Passionate about their work, they focus on B2B SaaS models related to management, technology, and mobility, particularly in the Seed or early stages. Although newly established, their portfolio already includes ChatCenter, Ntente, and Pulpo.

"Additio Investment Group is a global Syndicate of Healthcare & Life Sciences Investors that support high-integrity entrepreneurs with the potential to build great businesses. We pay particular attention to EU based opportunities that are in line with our health/care industry expertise and where we can add direct value, mainly: MedTech, and Digital Health/HealthTech with a particular clinical relevance. Average ticket size of €300-500K. AiG1 (fund 1) has been successfully allocated with a high profile portfolio of 5 companies. Our Partners are committed to hands-on value creation to our Portfolio through capital allocation, expertise and access to a valuable international Network."

Draper B1 is a seed and early-stage venture capital firm that invests in B2B and B2B2C startups. They are committed long-term investors specializing in seed-stage startups, having supported over 200 founders in the last decade. They maintain a hands-on approach, collaborating closely with entrepreneurs throughout their growth journey. Their focus is on empowering ambitious founders who are dedicated to making significant global impacts.

Invivo Partners, founded by Albert Ferrer and Luis Pareras, is a management company specializing in early-stage investments in the healthcare sector. They leverage a team of highly skilled professionals with expertise in scientific, technical, and financial analysis, supported by a strong network within the health ecosystem. Managed under Invivo Partners, Invivo Ventures operates based on the success of their initial fund, Healthequity, which closed at 60 million euros after registration with CNMV in 2019. Backed by prominent institutions and private investors, Invivo Partners has achieved notable exits and significant funding for their portfolio companies, emphasizing groundbreaking scientific innovations. Their strategic insights into Technology Transfer and ability to identify emerging trends position them as a leading player in Europe's Technology Transfer landscape.

Asabys Partners is a venture capital firm based in Barcelona that invests broadly in human healthcare. The firm is active in the health-tech and biopharma industries, targeting investments in Spain and internationally in highly innovative and transformative technologies. Motivated by the goal of pushing the boundaries of science and medicine, Asabys Partners sources and finances the most disruptive technologies and collaborates with top internal and external talents in the industry. With an entrepreneurial spirit, the firm seeks to be involved in the building and management of its companies, considering itself not just as investors, but as partners and collaborators to its portfolio companies.

Axilium Holding was established in Gothenburg, Sweden in 2018. Empowered with significant investment experience in several fields, a wide professional network, and a strong desire to succeed, the two founders established an innovative investment company focusing on early stage Technology and Life Science companies based predominantly in Europe.